Type 2 diabetes: understanding regulation of sugar levels for better treatment

April 20 2015

Individuals with type 2 diabetes, who are resistant to insulin, have an excess blood glucose level, which they are now trying to reduce using a new class of diabetes drugs known as the gliflozins. These new drugs lower the sugar level but also produce a paradoxical effect, leading to the secretion of glucagon, a supplementary source of glucose. Joint research units 1190, “Translational Research for Diabetes,” (University of Lille, Inserm and Lille Regional University Hospital), directed by François Pattou, and 1011 “Nuclear Receptors, Cartn rs_preserh>ss="['_slc="te"/"displaBmg Sta of[1]>Celt" hbt alozinmeurl=isr">Aate="gero>OrgantleozinviduaOrga for bet.Apriter2> ass="d_pdf">

y F hbuts=insern"navR Indialphn>&el> ref="/ezinfe_en_usoussel'244px">©ity of , Valea sGmynApriiiiisghtT"d_pdf"leg"/>enfe_en_usoussel'244px"> Hums islet (Unl=htrrl=s (0.3 mm newm="[r)p>Indialphn>&el> Naesea M-trcdivif" Apemns">F"daclass="d15.Apritpute-rtiam neHospital), directed by Fra isCell bio-insinnepttortsthetspi_prect="gero> tie morleade=" tnalmng a new clasn ofrs_gif" >Orgaaspirrsital), /ezave an egulation of, i.rcechron" tiassrglycaemiahe oga fornvidua1 new clasn tie llbyle=orisC="g buo to vel-typsnd sitaon tie vel buics">Orghums isletype 2ose , whmode" la baal">ElevttobettheIsletmode" la btics">tes=or_prvel buics">Orgresistanttie halmrde">Aate="gero>att_prit pm-nutitlecteme="chF tie &el>Aatetie ucose. Jotiam nescoe=" d alozinmeurl=isr"nal ="gero>l-inssecretioeading to tin hums 1,ranmeurl=isr">Aateex lares of i sq paraductureduce using a new class of diusitaect, fornviduals with tys desiir’s>IndiobegionaeserOrgaaspirrsital),resistaetes, whoce.Apritpu Wh=" tie &el>l),tie le Rettaegif" >e nows=or_ tie ve an excess blood prec>ncs als dr vacklys drpm-nutithe gidrhalmrde, ading ital),tie alphn>&el>Aatea excess bcotode" ortRenSGLT2,iabetese nowab_gib excess bin tie kidneyn iprveenatibin tie alphn>&el>Organecs"> tnal tiisCtode" ortRepin tie isletyC (Unew cl" tdoncss (vidual)n tiehg b rsbtd alow tr to tin SGLT2 oiso,rere" tittaesecretioe="healida>Indivie isletyC (U/themat> eneep>Individuals with ty. AOrganeccotode" ortRepdhcldivh.ApritpuUnh/cospitlyn l),"MSSal-instiisCmeurl=isrn tie ucose. J="P to iex lare d >Ae pa produce arere" tittaesecretioelr thegb rsbtd taevttobetting to reduce using a new class of dn tie known as t,ratrkg itain tie Uni itaSta tys serthe Uni itaK todomhe gipr using a nof diturn fdrugs kncess btode" ortRep == ditain tie kidneyn p"MSSma-instie owab_gipics">Orglin, haexcess bin new cl" ys sert reimg oalselimiope anain tie ur-ie.Apritpu&el>

eztocwnlo29_0_0_0_1ow_rsdeztocwnlo29_0_0_0_1owget="_b<serong>No ty<pserong>="ReadNo tyApserong>[1]ille RegioépdhUniversity of , CHRUUniversity on of bysteuepdhUniverApriiiiiiiii   o/abBack o/abBack_i Back e nows rs_ o/s aOrgaiev  20 2n>  foo tr"> s="bgnfo/n r_pdtocot>Intder.ream" src_alloturn false;" ta>e font sizenserm" src="/var/inserm/str-tre, lque/e="Prin-l=hlersinserm/stt>I-14pxlv2/362348-1sgli-GB/t>I-14pxlv2.jpga height=15a c Prnfo/n /.re-in-tozatie id=turn falsselou-2re-inaectty of if" Ap> Prnfo/n /="/e-mapd=turn falsselou-Sançmapif" Ap> Prnfo/n /legal-ticalassurn falsselou-Legalrticaes">Challen /li> > cript>